Try our Advanced Search for more refined results
Life Sciences - March, 2009
179 articles
- Securities Suit V. Axonyx Over Alzheimer's Drug Nixed
- AstraZeneca Sales Reps Exempt From OT: Judge
- Bayer Wants More Fraud Claims Nixed In Trasylol MDL
- Life Technologies, GE Settle DNA Kit Suit
- FDA Wants Unapproved Painkillers Taken Off Shelves
- Caraco Recalls Digoxin Over Irregular Dosage Fears
- Schering Sales Reps Not Exempt Under FLSA: Judge
- IBM, Others Sued Over Database Patent
- Watson Scores Win In J&J Patent Spat Over Concerta
- $185M Damage Award To Bard Not 'Monstrous': Judge
- 5th Circ. Lets Lilly Off Hook In Zyprexa Suicide
- Adapting Private Business To Climate Change
- Cordis, Boston Sci. Infringed Stents: Fed. Circ.
- GE Told To Pay $11.4M In False Advertising Case
- J&J Units Resolve Spat Over Razadyne-ER Patent
- Are 'Reverse Payments' Becoming More Reasonable?
- PTO Rules For Smith & Nephew In Suture Patent Fight
- DOJ Probing Par Over Megace Off-Label Marketing
- CORRECTED: 11th Circ. Sides With Feds In Endotec Device Suit
- Medtronic Recalls Brain Catheters Over Malfunctions
- Judge Denies Class Cert. In Funeral Home Cases
- Acacia Unit Sues P&G Over Videoconference Patent
- Merck, Gnosis Settle Vitamin False Marketing Case
- Law Preempts State Vaccine Liability Claims: 3rd Circ.
- Biolitec AG Escapes AMS Laser Patent Suit
- Mich. House Votes To Repeal Drugmaker Immunity
- Scams, Pay-For-Delay In FTC's Crosshairs This Year
- Dancer, Printers Settle With SEC Over Trading Scam
- BMS To Pay $2.1M To Settle FTC's Plavix Claims
- Doctors Told To Pay State Farm $15M In Fraud Case
- Senate Biologics Bill Draws Industry Ire
- FTC Seeks More Info On Thoratec, HeartWare Merger
- House Bill Would Ban Reverse Payment Settlements
- Medco Unit Poached Rival's Customers: Suit
- Revival Of USPTO Rules Spurs Call For Appeal
- Investor Asks To Replead Medtronic Securities Suit
- Lilly Loses Round Over Depositions In Zyprexa MDL
- Vista, Others Drop Claims In Neurontin Case V. Pfizer
- Medtronic Wins Stay In Abbott Stent Patent Suit
- Lannett, KV Bury Hatchet Over Vitamin Patents
- Lilly Can't Depose Mont. Docs In Zyprexa Suit: Judge
- Sens. Make Plea For Compromise On Patent Reform
- Synthes Bone Plate Suit Stayed For Patent Re-Exam
- Watson Recalls Irregular Heartbeat Drug
- CVT Shareholders Sue To Stop $1.4B Biotech Merger
- Wyeth Loses Bid To Extend Exclusivity For Cydectin
- Most Digital Firms License, Enforce IP Rights: Survey
- Teva Infringes Patents For Antibiotic Cubicin: Suit
- IP Partners Leave Lahive For McCarter & English
- Merck Loses JMOL Bid In ERISA Suit Over Vioxx Errors
- Generics Behaving Badly: Carve Outs, Off-Label Uses
- $14M Settlement Reached In Dura Securities Suit
- Organon Denied Ex Parte Contact In NuvaRing MDL
- Sepracor Sues Generics Makers Over Lunesta Patents
- AMS Prostate Laser Not Infringed By Biolitec: Court
- CORRECTED: Boston Scientific, Radiologist Settle Stent Patent Suit
- High Court Won't Hear Apotex's Risperdal Appeal
- Hogan Denies Conflict Of Interest In IP Suit
- J&J Unit Revises Label For Evra Patch In Canada
- Tafas V. Doll — Round II: 1 Down, 3 To Go
- Most Of ERISA Securities Case V. Pfizer Moves Ahead
- Court Won't Vacate Preemption Ruling In Redux Suit
- OSI Sues Teva, Mylan Over Cancer Drug Patents
- BD Nova Wins $5.9M In Fees In Abbott Patent Case
- Baby Bath Products Contain Formaldehyde: Suit
- FTC Declines To Challenge Reverse Payment Deal
- Rival Biologics Bills May Determine No. Of Patent Suits
- Mich. Legislators Fight To Nix Drugmakers' Immunity
- Fed. Circ. Sides With USPTO In Tafas Case
- DC's Pharmacy Benefits Disclosure Law Struck Down
- Bodee Yanks Zencore Over Blood Pressure Worries
- Stryker, Zimmer Get Kickback Suit Dismissed
- Biologics Concerns Shift From IP To Bioterrorism
- Warner Chilcott Sues Impax Again In Doryx IP Spat
- China Tests J&J Baby Products In Carcinogen Scare
- 8th Circ. Shuts Down Qui Tam Suit V. Hypoguard
- K&L Gates Snags Synthon VP, General Counsel
- Medtronic Gets OK To Seek Review Of Stent IP Ruling
- Teva, Medicis Strike Deal On Acne Drug Solodyn
- Pfizer In Divestiture Talks Over $68B Wyeth Merger
- As 1 Roche Investor Suit Ends, Another Moves Ahead
- Baker Donelson Launches Drug And Device Group
- Most Of Denture Cream Suit Against GSK Tossed
- Asbestos Claims Fuel Rise In US Caseload: Report
- AWP Judge Denies Bulk Of Abbott Subpoena For Docs
- NJ Judge Rebuffs Out-Of-Pocket Vioxx Class
- Rival Biologics Bill Introduced In House
- Welch Allyn Pulls Defibrillators Over Low Shock Issues
- Generics, Not Reglan Cos., Had Duty To Warn: Judge
- GSK Not Liable For La. Paxil Suicide: 5th Circ.
- Dura To Williams: Loss Causation Threshold
- Genzyme Hits Impax With IP Suit Over Renagel ANDA
- Isolagen To Hand Shareholders $5.25M
- Wellbutrin Antitrust Suit To Proceed On Most Claims
- Health Care Nanoscience: Regulation By Litigation
- Drug Cos. Hid SSRI Risks, Paid Docs Kickbacks: Suit
- Danish Drugmaker Hit With IP Suit Over Cancer Test
- New Post-Wyeth Proposed Claims Filed V. Medtronic
- Vertex Pharma Acquires ViroChem For $395M
- Boston Scientific Stole Stent Designs: Suit
- Single European Patent Would Spur Growth: EU
- House Told DOJ Needs Antitrust Watchdog For Banks
- Shire Sues Barr Over Kidney Drug ANDA
- Amerisource Must Pay Fees In Merger Suit: Court
- KV Sued Over Layoffs Following Production Freeze
- Steris Settles Class Action Over Reneged Benefits
- $46.8B Roche, Genentech Deal Ends Shareholder Suit
- Stiefel Sues Cobrek, Perrigo Over Generic Acne Drug
- Schering-Plough To Settle Securities Suit For $165M
- GSK Could Face Punitive Damages Over Paxil Case
- Fed. Circ. Upholds $5M Patent Judgment For Alaris
- Boston Scientific, J&J Unit End Aneurysm Patent Spat
- Bug In Cardinal Drug Pump Could Trigger Wrong Doses
- NJ Appeals Court Nixes $2.6M Ruling Against Roche
- Everett Bests Breckenridge Vitamin Patent Challenge
- Mylan Denied Summary Judgment In Antitrust Case
- Breast Implant Case Preempted By Riegel: Judge
- Life Tech Targets Oxford's $173M Royalty Claim
- Ex-Exec Admits Faking Cancer To Duck SEC
- Bill Aims To Create Approval Process For Biosimilars
- Oxycodone Method Obvious: Fed Circ.
- Plaintiff Asks To Unseal Seroquel Materials For FDA
- Obama Picks Public Health Expert To Head FDA
- Grand Jury Probes Stryker Over Device Marketing
- Novartis Unit Settles Shareholder Action For $30M
- Seroquel MDL Judge Upholds Ban On Foreign Evidence
- Covidien Tracheostomy Tube Recall Listed As Class I
- Amgen Settles Ky. Medicaid Fraud Suit For $2.4M
- Genzyme Warned Over Procedures At Drug Plant
- Dr. Reddy's Generic Doesn't Infringe Prilosec: Judge
- Medtronic Plaintiffs Can Revise Pleadings Post-Wyeth
- Investor Class Approved In Suit V. Boston Scientific
- Judge Tosses Medtronic Securities Class Action
- Wyeth Loses Bid To Drop Copyright Suit Over Ads
- Flonase Antitrust Plaintiffs Can Revise Class Bid
- Teva Hit With TRO Amid Lilly Evista Feud
- Chadbourne Scores Time Warner Chief Patent Counsel
- Sepracor Makes Peace With Barr Over Xopenex
- Dannon, Marketer Face Conditional Class In FLSA Suit
- Merck, Schering Merger Puts Pressure On Regulators
- Fed. Circ. To Go En Banc For Method Claims Question
- High Court Won't Hear Apotex Appeal Over Prilosec
- Preemption Motion Withdrawn In NuvaRing MDL
- Watson To Pay Elan $18M To Settle Naprelan IP Suit
- Consequences Of Banning Reverse Payments
- High Court Remands Cases In Light Of Wyeth
- Schering Merger Includes Legal Headaches For Merck
- FDA Reprimands Gilead Over Letairis Statements
- Medtronic MDL Judge Refuses Recusal
- Obama Overturns Stem Cell Research Ban
- Volvo Execs Face Bribery Charges Over Oil-For-Food
- Tobacco Cos. Win Dismissal Of Medicare Tax Spat
- J&J Seeks To Halt Bausch & Lomb 'Raid On Talent'
- Leibowitz's Past Opinions Point To Bolder FTC
- Genzyme Sues Lupin Over Generic Renagel
- Plaintiffs Push To Alter Class Motions In Flonase MDL
- Fed. Circ. Rulings Shake Up IP Landscape
- Judge Rejects Sanctions For WVa In Zyprexa MDL
- The Audacity Of Patent Reform
- 4th Circ. Affirms Verdict Against Pfizer In FMLA Case
- Patent Act's Damages Measure Sparks Debate
- Applera Wins Final Judgment In Enzo Patent Fight
- DOJ Eyes Medtronic Cardiac Ablation Marketing
- Novartis, Wyeth Unit Spar Over ReFacto Patent
- Preemption After Levine: A Practical Guide
- Dems Push To Undo Riegel After Wyeth Ruling
- Impact Of Wyeth Decision To Be Broad, Immediate
- Lannett, Albion Spar Over Generic Vitamins
- McCain Touts Drug Imports To Lower US Costs
- High Court Rejects Preemption In Wyeth
- Attys Seek $37.5M Of $125M Drug Prices MDL Deal
- Amicus Brief Asks High Court To Ease Bilski Test
- Docs Show AstraZeneca Knew Of Seroquel Risks
- J&J Fined $4.5M Over False Drug Promotions
- GSK Offers $28M To Settle Suits Over Defective Paxil
- Merck Sues Sandoz Over Plan For Generic Emend
- Smithfield Drops Claims In Neurontin Class Action
- KV Enjoined From Making, Shipping Unapproved Drugs
- Judge Threatens To Sanction Firm In Prempro MDL